Ototoxicity From Cisplatin Chemotherapy

DBCOND0070158Burns and Thermal Injuries Chemically-Induced Disorders

Ototoxicity From Cisplatin Chemotherapy is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Also known as: Cisplatin Ototoxicity
Classified under: Burns and Thermal Injuries
Chemically-Induced Disorders
Digestive System Signs and Symptoms
Epidermal and dermal conditions
Injuries by Anatomical Site
Occupational and Environmental Injuries
Otorhinolaryngologic Diseases
Public Health
Signs, Symptoms, and General Pathologies
Therapeutic and Rehabilitative Activities
Indicated drugs: Thiosulfuric acid

What you can answer from here — as of October 24, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

2Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Ototoxicity From Cisplatin Chemotherapy share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In